“The specific and significant COVID‐19 risk of ADE should have been and should be prominently and independently disclosed to research subjects currently in vaccine trials, as well as those being recruited for the trials and future patients after vaccine approval, in order to meet the medical ethics standard of patient comprehension for informed consent.”
The international Journal of Clinical Practice published this paper that shares additional findings on:
#InformedConsent & #AntidependentEnhancements.
Very disturbing findings 🔻
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645850/
The international Journal of Clinical Practice published this paper that shares additional findings on:
#InformedConsent & #AntidependentEnhancements.
Very disturbing findings 🔻
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645850/
PubMed Central (PMC)
Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease
Patient comprehension is a critical part of meeting medical ethics standards of informed consent in study designs. The aim of the study was to determine if sufficient literature exists to require clinicians to disclose the specific risk that COVID‐19 ...